Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Pegargiminase (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Jun 2010 Results reported at American Society of Clinical Oncology (ASCO) meeting, according to a Polaris media release.
- 07 Dec 2008 Planned end date changed from 1 Dec 2008 to 1 Dec 2010, according to ClinicalTrials.gov.
- 19 May 2007 New trial record.